EP3569222
Þurrduftssamsetning sem inniheldur andkólínvirkt efni, barkstera og beta-adrenvirkt efni til gjafar með innöndun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.7.2014EP published:
26.6.2024EP application number:
19182016.6
EP translation filed:
26.8.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
9.7.2034Expiry date:
9.7.2026Next due date:
31.7.2026
Title in English:
DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATIONLanguage of the patent:
English
Timeline
Today
10.7.2014EP application
26.6.2024EP Publication
26.8.2024Translation submitted
15.9.2024Registration published
9.7.2026Expires
Owner
Name:
Chiesi Farmaceutici S.p.A.Address:
Via Palermo, 26/A, 43122 Parma, IT
Inventor
Name:
Pasquali, IreneAddress:
43122 Parma, IT
Name:
Musa, RossellaAddress:
43122 Parma, IT
Name:
Schiaretti, FrancescaAddress:
43122 Parma, IT
Name:
Askey-Sarvar, AzitaAddress:
43122 Parma, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13176114Date:
11.7.2013Country:
EP
Number:
13194763Date:
28.11.2013Country:
EP
Classification
Categories:
A61K 9/00, A61K 47/12, A61K 47/26, A61K 45/06, A61K 31/167, A61K 31/40, A61K 31/573, A61P 11/00, A61P 11/06, A61P 11/08
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 22.8.2024
Expires: 9.7.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.7.2025
Expires: 9.7.2026
Payer: Árnason Faktor ehf.